A brief overview of drug-induced liver damage

被引:0
|
作者
Roy, Soumyadip [1 ]
Shah, Zalak [1 ]
Chakraborthy, G. S. [1 ]
机构
[1] Parul Univ, Parul Inst Pharm & Res, Dept Pharmacol, Vadodara, Gujarat, India
关键词
Liver injury; Drug; Hypersensitivity; Toxicity; Serum biomarkers; INDUCED HEPATOTOXICITY; ORAL MEDICATIONS; HEPATITIS-B; CELL-DEATH; INJURY; KERATIN-18; BIOMARKERS; FAILURE; RISK; MECHANISMS;
D O I
10.1186/s43162-024-00315-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug-induced liver injury (DILI) is a prevalent disorder that can be led on by almost all drug types. The majority of benign DILI cases become better after drug discontinuation. To stop the development of acute or chronic liver failure, it is crucial to identify and get rid of the offending substance as soon as feasible. DILI does not have any identified risk factors, but certain people may be more susceptible due to genetic vulnerability and previous liver disease. Some patients may exhibit indications of systemic hypersensitivity, even though the majority of patients have clinical symptoms that are the same as those of other liver illnesses. Rapid drug withdrawal and supportive care aimed at reducing uncomfortable symptoms comprise the treatment for drug- and herbal-induced liver damage.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Drug-Induced Liver Injury from Statins
    Meurer, Lindsay
    Cohen, Stanley Martin
    CLINICS IN LIVER DISEASE, 2020, 24 (01) : 107 - +
  • [42] Sex disparity and drug-induced liver injury
    Floreani, A.
    Bizzaro, D.
    Shalaby, S.
    Taliani, G.
    Burra, P.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (01) : 21 - 28
  • [43] Novel biomarkers for drug-induced liver injury
    Humphries, Christopher
    Dear, James W.
    CLINICAL TOXICOLOGY, 2023, 61 (08) : 567 - 572
  • [44] Drug-induced liver injury: a clinical update
    Ghabril, Marwan
    Chalasani, Naga
    Bjornsson, Einar
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (03) : 222 - 226
  • [45] Drug-induced liver failure due to rivaroxaban
    Peverelle, Matthew
    Asadi, Khashayar
    Sinclair, Marie
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2267 - 2268
  • [46] Drug-induced liver injury in the Australian setting
    Sistanizad, M.
    Peterson, G. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 115 - 120
  • [47] Animal models of drug-induced liver injury
    McGill, Mitchell R.
    Jaeschke, Hartmut
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (05): : 1031 - 1039
  • [48] Drug-induced liver injury: diagnosis of exclusion
    Maev, Igor V.
    Polunina, Tatiana E.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (08) : 611 - 620
  • [49] Drug-Induced Liver Injury in GI Practice
    Sandhu, Naemat
    Navarro, Victor
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (05) : 631 - 645
  • [50] Drug-Induced Liver Injury
    Gebran Abboud
    Neil Kaplowitz
    Drug Safety, 2007, 30 : 277 - 294